Jamieson is delighted to announce that it has advised the management team of Sterling Pharma Solutions (“Sterling”) on its acquisition by GHO Capital, the European specialist investor in healthcare.
Headquartered in Newcastle upon Tyne, UK, Sterling is a leading provider of API development and manufacturing, with a reputation for world class quality standards. This is reflected in Sterling’s long-term relationships with blue-chip pharmaceutical and animal health clients, as well as a strong track record with global regulators including the FDA and EMA. Sterling delivers a full-service offering of API development and GMP manufacturing to support its customers throughout the entire product lifecycle.
Sterling CEO, Kevin Cook, commented: “It was very reassuring to be supported by the Jamieson team. Their knowledge and experience helped us efficiently navigate a complex process. The advice and guidance we received resulted in a successful outcome“
The Jamieson team of Tom Burton and Ross Wheeler advised CEO Kevin Cook, CFO Tushar Jain, and the rest of the team during a competitive process on the terms of the transaction and the management incentive arrangements proposed by their new owner.
